Kintor Pharmaceutical Limited

HKEX:9939.HK

0.9 (HKD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42017 Q42017 Q22016 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 445.4990.6910.8650.3370.931.2331.0661.7920.19613.19334.4429.64
Short Term Investments 100.0110.0120.010.1270.5220.32800.0011600
Cash and Short Term Investments 455.4990.7020.8770.3871.0571.7551.3931.7920.19729.19334.4429.64
Net Receivables 00874.20401,054.16300000.6410.2940.284
Inventory 00.6030.6040.6060.3510.026000-00.2530.15
Other Current Assets 17.05833.69729.285183.698119.313141.26931.62115.04425.0814.9265.5892.981
Total Current Assets 472.5571.3391.5081.1771.5261.9231.4211.8070.22134.7640.57713.055
Non-Current Assets:
Property, Plant & Equipment, Net 190.7130.2730.2820.2790.2620.2350.1870.1530.1134.2023.7793.883
Goodwill 000000000000
Intangible Assets 148.940.2360.2360.2360.2360.210.210.1790.1799.8170.0040.004
Goodwill and Intangible Assets 148.940.2360.2360.2360.2360.210.210.1790.1799.8170.0040.004
Long Term Investments 7.9970.0180.0180.01900000000
Tax Assets 23.13300000000000
Other Non-Current Assets 49.025-0.526-0.536-0.5340-0.445-0.396-0.333-0.2920.3570.0280.007
Total Non-Current Assets 396.6750.5260.5360.5340.4980.4450.3960.3330.29214.3763.8113.895
Total Assets 869.2321.8742.0551.752.0682.4011.8512.1770.55349.13644.38916.95
Liabilities & Equity:
Current Liabilities:
Account Payables 68.28881.28378.453101.44644.727.93828.681124.8122.42000
Short Term Debt 118.23104.774103.33556.5869.4697.59486.313112.74861.78615170
Tax Payables 0.4321.0841.8992.9482.0971.1511.17900000
Deferred Revenue 0-104.774-103.335-56.586-9.469-7.594-86.313-112.748-61.786000
Other Current Liabilities 37.7886.749134.44181.464163.47433.26853.160.51758.3770.5050.5510.1
Total Current Liabilities 224.730.2740.3180.3420.220.070.1690.2380.14315.50517.5510.1
Non-Current Liabilities:
Long Term Debt 135.69217.792183.051177.953150.2640.132135.3999.4362.3113000
Deferred Revenue Non-Current 19.65718.13219.9523.6114.009-38.686-38.683-38.72-38.818000
Deferred Tax Liabilities Non-Current 31.04338.81838.81838.81838.81838.81838.81838.81838.818000
Other Non-Current Liabilities 0-549.055-483.287-440.423-385.887131.968-174.073-138.1560000
Total Non-Current Liabilities 186.390.2140.1780.170.1480.1320.1350.09941.1293000
Total Liabilities 411.120.5490.560.5630.4130.2410.3440.3760.18445.50517.5510.1
Equity:
Preferred Stock 3,784.66400000000000
Common Stock 0.3150000000019.65519.65518.781
Retained Earnings 0-2.936-2.724-2.288-1.769-1.253-0.927-0.615-0.419-104.087-80.88-57.87
Accumulated Other Comprehensive Income/Loss 60.730.0840.1153.47565.4893,412.9782,435.0532,415.059788.726000
Other Total Stockholders Equity -3,387.5972,936.9662,725.02401,770.857-2,157.617-1,506.165-1,798.732-369.27788.06288.06255.939
Total Shareholders Equity 458.1121.3261.4951.1881.6552.161.5081.8010.373.63126.83816.849
Total Equity 458.1121.3261.4951.1881.6552.161.5081.8010.373.63126.83816.849
Total Liabilities & Shareholders Equity 869.2321,874.142,055.1361,750.382,067.9892,400.9191,851.4752,177.123553.37649.13644.38916.95